Adverse event signal mining and severe adverse event influencing factor analysis of Lumateperone based on FAERS database
Collectively, this study provides critical insights into the safety profile of Lumateperone. It highlights the need for cautious use in high-risk populations, such as females and individuals with bipolar II disorder, and emphasizes the importance of monitoring for AEs, including dizziness and tardive dyskinesia. Healthcare also should remain alert to potential AEs not listed in the prescribing information to ensure medical safety.
Authors
- Y. Hao
- Chunhua Zhou (ORCID: https://orcid.org/0000-0003-1543-9000)
- Yan Liu (ORCID: https://orcid.org/0000-0002-7682-3498)
- Jing Yu (ORCID: https://orcid.org/0000-0002-8694-8948)
- Yanjing Zhang (ORCID: https://orcid.org/0009-0004-9526-6502)
- Bingyu Song
- Jing Wang (ORCID: https://orcid.org/0000-0002-3793-3264)
Institutions
- Hebei Medical University (CN)
- First Affiliated Hospital of Hebei Medical University (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2024-09-23
- DOI
- https://doi.org/10.3389/fphar.2024.1472648
- Citations
- 4
- Primary Topic
- Pharmacovigilance and Adverse Drug Reactions
- Type
- article
- Field-Weighted Citation Impact
- 1.40
Funders
- Health Commission of Hebei Province